TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
PEPTONIC medical AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
24,931
|
29,158
|
23,009 |
Financial expenses |
1,560
|
3,718
|
52 |
Earnings before taxes |
-28,606
|
-24,629
|
-53,581 |
EBITDA |
-23,455
|
-20,124
|
-33,930 |
Total assets |
71,692
|
57,302
|
60,715 |
Current assets |
27,146
|
20,952
|
19,695 |
Current liabilities |
21,099
|
23,432
|
22,892 |
Equity capital |
50,593
|
31,468
|
37,823 |
- share capital |
25,773
|
16,221
|
13,935 |
Employees (average) |
37
|
33
|
34 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
70.6%
|
54.9%
|
62.3% |
Turnover per employee |
674
|
884
|
677 |
Profit as a percentage of turnover |
-114.7%
|
-84.5%
|
-232.9% |
Return on assets (ROA) |
-37.7%
|
-36.5%
|
-88.2% |
Current ratio |
128.7%
|
89.4%
|
86.0% |
Return on equity (ROE) |
-56.5%
|
-78.3%
|
-141.7% |
Change turnover |
-4,377
|
8,013
|
7,533 |
Change turnover % |
-15%
|
38%
|
49% |
Chg. No. of employees |
4
|
-1
|
15 |
Chg. No. of employees % |
12%
|
-3%
|
79% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.